Furthermore, decreased tumor PD-L1 expression was observed in the PF543 group compared with the control group, and the PD-1 expression on CD45+ cells was slightly decreased after the PF543 treatment (Fig. 2k and Supplementary Fig. 2e–g). Here, PTPRC is linked to neoplasm.